Leerink and TD Cowen are acting as joint book running managers for the offering. The deal size was increased to $400M from $250M and priced below last closing price of $48.06.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on CLDX:
- Celldex Therapeutics Announces Pricing of Upsized $400 Million Public Offering of Common Stock
- Celldex announces $250M offering of common stock
- Celldex Therapeutics Announces Proposed Public Offering of Common Stock
- Biotech Alert: Searches spiking for these stocks today
- Celldex price target raised to $90 from $72 at Guggenheim